Bolt Biotherapeutics
BOLT
BOLT
39 hedge funds and large institutions have $27.1M invested in Bolt Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.05% less ownership
Funds ownership: 3.23% → 3.19% (-0.05%)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$598K | |
| 2 | +$147K | |
| 3 | +$107K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$71.9K |
| 5 |
Jane Street
New York
|
+$63K |
Top Sellers
| 1 | -$442K | |
| 2 | -$392K | |
| 3 | -$84.5K | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$42.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$11.9K |